STOCK TITAN

Endava Announces Second Quarter Fiscal Year 2025 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Endava (NYSE: DAVA) reported Q2 FY2025 results with revenue reaching £195.6 million, representing a 6.6% year-over-year increase and 9.1% at constant currency. The company announced a $100 million share repurchase program, subject to shareholder approval in March 2025.

Key financial metrics include diluted EPS of £0.11 (down from £0.14), adjusted diluted EPS remaining stable at £0.30, and profit before tax of £2.5 million (down from £10.6 million). The company maintained strong cash position with £60.1 million in cash and cash equivalents.

Geographic revenue distribution showed North America at 39%, Europe at 24%, UK at 32%, and rest of world at 5%. The company serves 141 clients with over £1 million in revenue, with top 10 clients accounting for 36% of revenue. For Q3 FY2025, Endava expects revenue between £198.0-£200.0 million, representing 13-14% constant currency growth.

Endava (NYSE: DAVA) ha riportato i risultati del secondo trimestre dell'anno fiscale 2025, con un fatturato che ha raggiunto 195,6 milioni di sterline, rappresentando un incremento del 6,6% rispetto all'anno precedente e del 9,1% a valuta costante. L'azienda ha annunciato un programma di riacquisto di azioni da 100 milioni di dollari, soggetto all'approvazione degli azionisti a marzo 2025.

I principali indicatori finanziari includono un utile per azione diluito di £0,11 (in calo rispetto a £0,14), un utile per azione diluito rettificato stabile a £0,30 e un profitto ante imposte di £2,5 milioni (in calo rispetto a £10,6 milioni). L'azienda ha mantenuto una solida posizione di liquidità con 60,1 milioni di sterline in contante e equivalenti.

La distribuzione geografica del fatturato mostra il Nord America al 39%, l'Europa al 24%, il Regno Unito al 32% e il resto del mondo al 5%. L'azienda serve 141 clienti con oltre 1 milione di sterline di fatturato, con i primi 10 clienti che rappresentano il 36% del fatturato. Per il terzo trimestre dell'anno fiscale 2025, Endava prevede un fatturato compreso tra 198,0-200,0 milioni di sterline, rappresentando una crescita del 13-14% a valuta costante.

Endava (NYSE: DAVA) reportó los resultados del segundo trimestre del año fiscal 2025, con ingresos que alcanzaron 195,6 millones de libras esterlinas, lo que representa un aumento del 6,6% en comparación con el año anterior y del 9,1% a moneda constante. La compañía anunció un programa de recompra de acciones de 100 millones de dólares, sujeto a la aprobación de los accionistas en marzo de 2025.

Los principales indicadores financieros incluyen un EPS diluido de £0,11 (bajando de £0,14), un EPS diluido ajustado que se mantiene estable en £0,30, y una ganancia antes de impuestos de £2,5 millones (bajando de £10,6 millones). La compañía mantiene una sólida posición de efectivo con 60,1 millones de libras esterlinas en efectivo y equivalentes.

La distribución geográfica de los ingresos muestra a América del Norte en un 39%, Europa en un 24%, Reino Unido en un 32% y el resto del mundo en un 5%. La compañía atiende a 141 clientes con más de 1 millón de libras esterlinas en ingresos, siendo los 10 principales clientes responsables del 36% de los ingresos. Para el tercer trimestre del año fiscal 2025, Endava espera ingresos entre 198,0-200,0 millones de libras esterlinas, representando un crecimiento del 13-14% a moneda constante.

Endava (NYSE: DAVA)는 2025 회계연도 2분기 실적을 보고하며, 매출이 1억 9,560만 파운드에 도달했으며, 이는 전년 대비 6.6% 증가하고, 일정 환율 기준으로는 9.1% 증가한 수치입니다. 회사는 1억 달러 규모의 자사주매입 프로그램을 발표했으며, 이는 2025년 3월 주주 승인을 받아야 합니다.

주요 재무 지표로는 희석 주당순이익(EPS)이 £0.11(£0.14에서 감소), 조정된 희석 EPS는 £0.30으로 안정적이며, 세전 이익은 £250만(£1,060만에서 감소)입니다. 회사는 6,010만 파운드의 현금 및 현금성 자산으로 강력한 현금 위치를 유지하고 있습니다.

지리적 매출 분포는 북미 39%, 유럽 24%, 영국 32%, 기타 지역 5%를 나타냅니다. 이 회사는 141명의 고객에게 100만 파운드 이상의 매출을 제공하며, 상위 10명의 고객이 매출의 36%를 차지합니다. 2025 회계연도 3분기 동안 Endava는 1억 9,800만-2억 파운드의 매출을 예상하며, 이는 일정 환율 기준으로 13-14% 성장할 것으로 보입니다.

Endava (NYSE: DAVA) a publié les résultats du deuxième trimestre de l'exercice 2025, avec des revenus atteignant 195,6 millions de livres sterling, représentant une augmentation de 6,6% par rapport à l'année précédente et de 9,1% à taux de change constant. L'entreprise a annoncé un programme de rachat d'actions de 100 millions de dollars, soumis à l'approbation des actionnaires en mars 2025.

Les principaux indicateurs financiers comprennent un BPA dilué de £0,11 (en baisse par rapport à £0,14), un BPA dilué ajusté restant stable à £0,30, et un bénéfice avant impôts de £2,5 millions (en baisse par rapport à £10,6 millions). L'entreprise a maintenu une solide position de trésorerie avec 60,1 millions de livres sterling en espèces et équivalents.

La répartition géographique des revenus montre l'Amérique du Nord à 39%, l'Europe à 24%, le Royaume-Uni à 32% et le reste du monde à 5%. L'entreprise sert 141 clients avec plus de 1 million de livres sterling de revenus, les 10 principaux clients représentant 36% des revenus. Pour le troisième trimestre de l'exercice 2025, Endava s'attend à des revenus compris entre 198,0-200,0 millions de livres sterling, représentant une croissance de 13-14% à taux de change constant.

Endava (NYSE: DAVA) berichtete über die Ergebnisse des zweiten Quartals des Geschäftsjahres 2025, wobei der Umsatz 195,6 Millionen Pfund erreichte, was einem Anstieg von 6,6% im Vergleich zum Vorjahr und 9,1% bei konstanten Währungen entspricht. Das Unternehmen kündigte ein Aktienrückkaufprogramm über 100 Millionen Dollar an, das der Genehmigung der Aktionäre im März 2025 unterliegt.

Wichtige Finanzkennzahlen umfassen einen verwässerten Gewinn pro Aktie von £0,11 (rückläufig von £0,14), einen stabilen bereinigten verwässerten Gewinn pro Aktie von £0,30 und einen Gewinn vor Steuern von £2,5 Millionen (rückläufig von £10,6 Millionen). Das Unternehmen hielt eine starke Liquiditätsposition mit 60,1 Millionen Pfund in Bargeld und Barmitteln.

Die geografische Umsatzverteilung zeigt Nordamerika mit 39%, Europa mit 24%, das Vereinigte Königreich mit 32% und den Rest der Welt mit 5%. Das Unternehmen bedient 141 Kunden mit über 1 Million Pfund Umsatz, wobei die zehn größten Kunden 36% des Umsatzes ausmachen. Für das dritte Quartal des Geschäftsjahres 2025 erwartet Endava einen Umsatz zwischen 198,0-200,0 Millionen Pfund, was einem Wachstum von 13-14% bei konstanten Währungen entspricht.

Positive
  • Revenue increased 6.6% YoY to £195.6 million
  • Announced $100 million share repurchase program
  • Strong Q3 guidance with 13-14% expected constant currency growth
  • Maintained adjusted diluted EPS at £0.30
  • Healthy cash position with £60.1 million in cash and cash equivalents
Negative
  • Profit before tax declined to £2.5 million from £10.6 million YoY
  • Diluted EPS decreased to £0.11 from £0.14 YoY
  • Number of £1M+ revenue clients decreased to 141 from 150 YoY
  • Adjusted profit before tax margin declined to 11.2% from 12.4% YoY

Insights

Endava's Q2 FY2025 results reveal a company navigating through a strategic transition phase. The 6.6% revenue growth (9.1% at constant currency) demonstrates resilience, but the more telling story lies in the evolving business mix and profitability dynamics.

The significant compression in profit before tax to £2.5 million from £10.6 million year-over-year warrants attention. This 76.4% decline in profitability, despite revenue growth, suggests increased operational costs or strategic investments that haven't yet yielded returns. However, the adjusted metrics show more stability, with adjusted profit before tax at £21.8 million (11.2% margin) indicating underlying business strength once exceptional items are excluded.

The newly announced $100 million share repurchase program is particularly strategic given the current market conditions. With £60.1 million in cash and robust operating cash flow of £32.0 million, the company maintains financial flexibility while returning capital to shareholders. This balanced approach to capital allocation suggests management's confidence in future cash generation capabilities.

The revenue mix transformation reveals important strategic shifts:

  • Healthcare vertical's growth from 4% to 12% indicates successful diversification into more stable, recession-resistant sectors
  • The decline in Payments (from 26% to 19%) and TMT (from 23% to 19%) suggests a deliberate rebalancing away from more volatile tech-dependent sectors
  • North American revenue contribution increase to 39% demonstrates successful geographic expansion in the world's largest tech market

The stable headcount of 11,668 despite revenue growth points to improved operational efficiency and higher revenue per employee. However, the slight decrease in million-pound clients (141 vs 150) and increased concentration among top 10 clients (36% vs 34%) suggests a need to accelerate new client acquisition.

Looking forward, the company's guidance for Q3 FY2025 projects revenue of £198.0-200.0 million, implying 13.0-14.0% constant currency growth. This acceleration from Q2's growth rate, combined with the company's strategic positioning in AI solutions, indicates potential for margin recovery as these initiatives mature.

Q2 FY2025

6.6% Year on Year Revenue Increase to £195.6 million

9.1% Revenue Increase at Constant Currency

Diluted EPS £0.11 compared to £0.14 in the prior comparative period

Adjusted Diluted EPS £0.30 unchanged from the prior comparative period

Endava announces $100 million share repurchase program

LONDON--(BUSINESS WIRE)-- Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended December 31, 2024, the second quarter of its 2025 fiscal year ("Q2 FY2025").

"Our results for the second quarter of FY25 were solid with improved profitability. Gen AI adoption is becoming a key priority for clients. With our hands-on experience, coupled with deep industry expertise, we believe we are in a strong position to cut through the hype that our clients are exposed to regarding AI and to work with them to deliver real business value. Additionally, today, we announced our first share buyback program totaling $100 million as we reinforce our commitment to optimising our capital allocation," said John Cotterell, Endava's CEO.

SECOND QUARTER FISCAL YEAR 2025 FINANCIAL HIGHLIGHTS:

  • Revenue for Q2 FY2025 was £195.6 million, an increase of 6.6% compared to £183.6 million in the same period in the prior year.
  • Revenue increase at constant currency (a non-IFRS measure)* was 9.1% for Q2 FY2025.
  • Profit before tax for Q2 FY2025 was £2.5 million, compared to £10.6 million in the same period in the prior year.
  • Adjusted profit before tax (a non-IFRS measure)* for Q2 FY2025 was £21.8 million, or 11.2% of revenue, compared to £22.7 million, or 12.4% of revenue, in the same period in the prior year.
  • Profit for the period was £6.9 million, resulting in a diluted earnings per share ("EPS") of £0.11, compared to profit of £8.3 million and diluted EPS of £0.14 in the same period in the prior year.
  • Adjusted profit for the period (a non-IFRS measure)* was £17.9 million, resulting in adjusted diluted EPS (a non-IFRS measure)* of £0.30, compared to adjusted profit for the period of £17.5 million and adjusted diluted EPS of £0.30 in the same period in the prior year.

CASH FLOW:

  • Net cash from operating activities was £32.0 million in Q2 FY2025, compared to net cash from operating activities of £35.0 million in the same period in the prior year.
  • Adjusted free cash flow (a non-IFRS measure)* was £31.6 million in Q2 FY2025, compared to £33.6 million in the same period in the prior year.
  • At December 31, 2024, Endava had cash and cash equivalents of £60.1 million, compared to £62.4 million at June 30, 2024.

* Definitions of the non-IFRS measures used by the Company and a reconciliation of such measures to the related IFRS financial measure can be found under the sections below titled “Non-IFRS Financial Information” and “Reconciliation of IFRS Financial Measures to Non-IFRS Financial Measures.”

OTHER METRICS FOR THE QUARTER ENDED DECEMBER 31, 2024:

  • Headcount totaled 11,668 at December 31, 2024, with an average of 10,456 operational employees in Q2 FY2025, compared to a headcount of 11,539 at December 31, 2023 and an average of 10,461 operational employees in the same period in the prior year.
  • Number of clients with over £1 million in revenue on a rolling twelve-month basis was 141 at December 31, 2024, compared to 150 clients at December 31, 2023.
  • Top 10 clients accounted for 36% of revenue in Q2 FY2025, compared to 34% in the same period in the prior year.
  • By geographic region, 39% of revenue was generated in North America, 24% was generated in Europe, 32% was generated in the United Kingdom and 5% was generated in the rest of the world in Q2 FY2025. This compares to 31% in North America, 26% in Europe, 34% in the United Kingdom and 9% in the Rest of the World in the same period in the prior year.
  • By industry vertical, 19% of revenue was generated from Payments, 19% from BCM, 9% from Insurance, 19% from TMT, 9% from Mobility, 12% from Healthcare, and 13% from Other in Q2 FY2025. This compares to 26% from Payments, 14% from BCM, 8% from Insurance, 23% from TMT, 11% from Mobility, 4% from Healthcare, and 14% from Other in the same period in the prior year.

OUTLOOK:

Third Quarter Fiscal Year 2025:

Endava expects revenue will be in the range of £198.0 million to £200.0 million, representing a constant currency revenue increase of between 13.0% and 14.0% on a year over year basis. Endava expects adjusted diluted EPS to be in the range of £0.31 to £0.32 per share.

Full Fiscal Year 2025:

Endava expects revenue will be in the range of £795.0 million to £800.0 million, representing a constant currency revenue increase of between 8.5% and 9.0% on a year over year basis. Endava expects adjusted diluted EPS to be in the range of £1.20 to £1.23 per share.

This above guidance for the third quarter and full fiscal year 2025 assumes the exchange rates on January 31, 2025 (when the exchange rate was 1 British Pound to 1.24 US Dollar and 1.20 Euro).

Endava is not able, at this time, to reconcile its expectations for the third quarter and full fiscal year 2025 for a rate of revenue growth or decline at constant currency or adjusted diluted EPS to their respective most directly comparable IFRS measures as a result of the uncertainty regarding, and the potential variability of, reconciling items such as share-based compensation expense, amortisation of acquired intangible assets, foreign currency exchange losses / (gains), net, and fair value movement of contingent consideration, as applicable. Accordingly, a reconciliation is not available without unreasonable effort, although it is important to note that these factors could be material to Endava's results computed in accordance with IFRS.

The guidance provided above is forward-looking in nature. Actual results may differ materially. See “Forward-Looking Statements” below.

SHARE REPURCHASE PROGRAM:

Endava's Board of Directors has approved a share repurchase program authorizing the Company to repurchase up to $100 million of its Class A ordinary shares (in the form of American Depositary Shares) as part of Endava’s evolving approach to capital allocation. As Endava is a UK-incorporated company, execution of the share repurchase program is subject to shareholder approval, which we intend to seek at a general meeting to be held on or around March 14, 2025. The shareholder authorization, if approved, will be valid for five years.

The Company intends to fund the share repurchases through a combination of cash generated from operations and drawing debt funding through its revolving credit facility. The exact number of shares to be repurchased by the Company under the share repurchase program, if any, is not guaranteed, including whether the Company utilizes the full $100 million approved by the Board of Directors. Depending on market conditions and other factors, and following receipt of shareholder approval, these repurchases may be commenced or suspended at any time or periodically without prior notice.

The Company may repurchase shares from time to time on the open market or in privately negotiated transactions, or otherwise in accordance with applicable federal securities laws, including Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The timing, manner, price and amount of any repurchases will be determined by the discretion of management, depending on market conditions and other factors.

CONFERENCE CALL DETAILS:

The Company will host a conference call at 8:00 am ET today, February 20, 2025, to review its Q2 FY2025 results. To participate in Endava’s Q2 FY2025 earnings conference call, please dial in at least five minutes prior to the scheduled start time (844) 481-2736 or (412) 317-0665 for international participants, Conference ID: Endava Call.

Investors may listen to the call on Endava’s Investor Relations website at http://investors.Endava.com. The webcast will be recorded and available for replay until Thursday March 20, 2025.

ABOUT ENDAVA PLC:

We are a leading provider of next-generation technology services, dedicated to enabling our customers to drive real impact and meaningful change. By combining world-class engineering, deep industry expertise and a customer-centric mindset, we consult and partner with our customers to create technological solutions that fuel transformation and empower businesses to succeed in the AI-driven digital shift. From ideation to production, we support our customers with tailor-made solutions at every stage of their digital transformation, regardless of industry, region or scale.

Endava’s clients span payments, insurance, finance and banking, technology, media, telecommunications, healthcare and life sciences, mobility, retail and consumer goods and more. As of December 31, 2024, 11,668 Endavans are helping clients break new ground across locations in Europe, the Americas, Asia Pacific and the Middle East.

NON-IFRS FINANCIAL INFORMATION:

To supplement Endava’s Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Cash Flows presented in accordance with IFRS, the Company uses non-IFRS measures of certain components of financial performance in this press release. These measures include revenue growth/(decline) rate at constant currency, adjusted profit before tax, adjusted profit for the period, adjusted diluted EPS and adjusted free cash flow.

Revenue growth/(decline) rate at constant currency is calculated by translating revenue from entities reporting in foreign currencies into British Pounds using the comparable foreign currency exchange rates from the prior period. For example, the average currency rates in effect for the fiscal quarter ended December 31, 2023 were used to convert revenue for the fiscal quarter ended December 31, 2024 and the revenue for the comparable prior period.

Adjusted profit before tax ("Adjusted PBT") is defined as the Company’s profit before tax adjusted to exclude the impact of share-based compensation expense, amortisation of acquired intangible assets, realised and unrealised foreign currency exchange (gains)/losses, net, restructuring costs, and fair value movement of contingent consideration, all of which are non-cash items except for realised foreign currency exchange (gains)/losses, net. Our Adjusted PBT margin is our Adjusted PBT as a percentage of our total revenue.

Adjusted profit for the period is defined as Adjusted PBT less the adjusted tax charge for the period. The adjusted tax charge is the tax charge adjusted for the tax impact of the adjustments to PBT and the release of the deferred tax liability relating to Romanian withholding tax.

Adjusted diluted EPS is defined as Adjusted profit for the period, divided by weighted average number of shares outstanding - diluted.

Adjusted free cash flow is the Company’s net cash from operating activities, plus grants received, less net purchases of non-current assets (tangible and intangible). Adjusted free cash flow is not intended to be a measure of residual cash available for management's discretionary use since it omits significant sources and uses of cash flow, including mandatory debt repayments and changes in working capital.

Management believes these measures help illustrate underlying trends in the Company's business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing the Company's business and evaluating its performance. Management also believes the presentation of its non-IFRS financial measures enhances an investor’s overall understanding of the Company’s historical financial performance. The presentation of the Company’s non-IFRS financial measures is not meant to be considered in isolation or as a substitute for the Company’s financial results prepared in accordance with IFRS, and its non-IFRS measures may be different from non-IFRS measures used by other companies. Investors should review the reconciliation of the Company’s non-IFRS financial measures to the comparable IFRS financial measures included below, and not rely on any single financial measure to evaluate the Company’s business.

FORWARD-LOOKING STATEMENTS:

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” "intends," "outlook," “may,” “will,” and other similar terms and phrases. Such forward-looking statements include, but are not limited to, the statements regarding trends with respect to the adoption of generative AI, the share repurchase program, including Endava's anticipated receipt of shareholder approval for the share repurchase program, and management's financial outlook for the third quarter and full fiscal year 2025. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: Endava’s ability to achieve its revenue growth goals including as a result of a slower conversion of its pipeline; Endava's expectations of future operating results or financial performance; Endava’s ability to accurately forecast and achieve its announced guidance; Endava's ability to retain existing clients and attract new clients, including its ability to increase revenue from existing clients and diversify its revenue concentration; Endava’s ability to attract and retain highly-skilled IT professionals at cost-effective rates; Endava's ability to successfully identify acquisition targets, consummate acquisitions and successfully integrate acquired businesses and personnel; Endava's ability to penetrate new industry verticals and geographies and grow its revenue in current industry verticals and geographies; Endava’s ability to maintain favorable pricing and utilization rates to support its gross margin; the effects of increased competition as well as innovations by new and existing competitors in its market; the size of Endava's addressable market and market trends; Endava’s ability to adapt to technological change and industry trends and innovate solutions for its clients; Endava's plans for growth and future operations, including its ability to manage its growth; Endava's ability to effectively manage its international operations, including Endava's exposure to foreign currency exchange rate fluctuations; Endava's future financial performance, including trends in revenue, cost of sales, gross profit, selling, general and administrative expenses, finance income and expense and taxes; the impact of unstable market and economic conditions, including as a result of actual or anticipated changes in interest rates, economic inflation and the responses by central banking authorities to control such inflation; and the impact of political instability, natural disaster, events of terrorism and wars, including the military conflict between Ukraine and Russia and related sanctions, as well as other risks and uncertainties discussed in the “Risk Factors” section of Endava's Annual Report on Form 20-F for the year ended June 30, 2024 filed with the SEC on September 19, 2024 and in other filings that Endava makes from time to time with the SEC. In addition, the forward-looking statements included in this press release represent Endava’s views and expectations as of the date hereof and are based on information currently available to Endava. Endava anticipates that subsequent events and developments may cause its views to change. Endava specifically disclaims any obligation to update the forward-looking statements in this press release except as required by law. These forward-looking statements should not be relied upon as representing Endava’s views as of any date subsequent to the date hereof.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023(1)

2024

2023

 

£’000

£’000

£’000

£’000

REVENUE

390,641

 

371,973

 

195,589

 

183,552

 

Cost of sales

 

 

 

 

Direct cost of sales

(283,066

)

(259,412

)

(143,546

)

(132,093

)

Allocated cost of sales

(13,898

)

(13,218

)

(7,025

)

(6,586

)

Total cost of sales

(296,964

)

(272,630

)

(150,571

)

(138,679

)

GROSS PROFIT

93,677

 

99,343

 

45,018

 

44,873

 

Selling, general and administrative expenses

(87,314

)

(78,618

)

(43,345

)

(40,255

)

OPERATING PROFIT

6,363

 

20,725

 

1,673

 

4,618

 

Net finance income/(expense)

354

 

7,193

 

831

 

5,987

 

PROFIT BEFORE TAX

6,717

 

27,918

 

2,504

 

10,605

 

Tax on profit on ordinary activities

2,381

 

(7,205

)

4,347

 

(2,258

)

PROFIT FOR THE PERIOD

9,098

 

20,713

 

6,851

 

8,347

 

OTHER COMPREHENSIVE INCOME

 

 

 

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

Exchange differences on translating foreign operations and net investment hedge impact

(13,813

)

1,869

 

9,527

 

(2,873

)

TOTAL COMPREHENSIVE INCOME/(LOSS) FOR THE PERIOD ATTRIBUTABLE TO OWNERS OF THE COMPANY

(4,715

)

22,582

 

16,378

 

5,474

 

 

 

 

 

 

EARNINGS PER SHARE (EPS):

 

 

 

 

Weighted average number of shares outstanding - Basic

59,269,752

 

58,101,072

 

59,488,389

 

58,300,691

 

Weighted average number of shares outstanding - Diluted

59,472,250

 

58,367,296

 

59,628,436

 

58,602,535

 

Basic EPS (£)

0.15

 

0.36

 

0.12

 

0.14

 

Diluted EPS (£)

0.15

 

0.35

 

0.11

 

0.14

 

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

December 31, 2024

June 30, 2024

December 31, 2023 (1)

 

£’000

£’000

£’000

ASSETS - NON-CURRENT

 

 

 

Goodwill

511,647

 

515,724

 

254,180

 

Intangible assets

114,100

 

127,797

 

60,818

 

Property, plant and equipment

16,603

 

20,638

 

23,181

 

Lease right-of-use assets

47,459

 

53,294

 

54,949

 

Deferred tax assets

21,466

 

18,323

 

22,084

 

Financial assets and other receivables

9,005

 

10,499

 

6,386

 

TOTAL

720,280

 

746,275

 

421,598

 

ASSETS - CURRENT

 

 

 

Trade and other receivables

190,059

 

193,673

 

172,002

 

Corporation tax receivable

10,072

 

11,402

 

2,127

 

Financial assets

118

 

183

 

186

 

Cash and cash equivalents

60,065

 

62,358

 

198,602

 

TOTAL

260,314

 

267,616

 

372,917

 

TOTAL ASSETS

980,594

 

1,013,891

 

794,515

 

LIABILITIES - CURRENT

 

 

 

Lease liabilities

14,457

 

14,450

 

13,782

 

Trade and other payables

106,260

 

116,569

 

85,347

 

Corporation tax payable

9,784

 

8,556

 

4,565

 

Contingent consideration

3,577

 

8,444

 

5,335

 

Deferred consideration

4,170

 

5,840

 

2,499

 

TOTAL

138,248

 

153,859

 

111,528

 

LIABILITIES - NON CURRENT

 

 

 

Borrowings

123,669

 

144,754

 

 

Lease liabilities

37,711

 

43,557

 

45,645

 

Deferred tax liabilities

24,719

 

30,814

 

13,541

 

Contingent consideration

1,155

 

 

 

Deferred consideration

 

943

 

3,280

 

Other liabilities

377

 

509

 

543

 

TOTAL

187,631

 

220,577

 

63,009

 

EQUITY

 

 

 

Share capital

1,189

 

1,180

 

1,167

 

Share premium

21,280

 

21,280

 

17,753

 

Merger relief reserve

63,440

 

63,440

 

48,139

 

Retained earnings

602,688

 

573,640

 

566,589

 

Other reserves

(33,872

)

(20,059

)

(13,644

)

Investment in own shares

(10

)

(26

)

(26

)

TOTAL

654,715

 

639,455

 

619,978

 

TOTAL LIABILITIES AND EQUITY

980,594

 

1,013,891

 

794,515

 

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

Six Months Ended
December 31(2)

Three Months Ended
December 31(2)

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

OPERATING ACTIVITIES

 

 

 

 

Profit for the period

9,098

 

20,713

 

6,851

 

8,347

 

Income tax charge

(2,381

)

7,205

 

(4,347

)

2,258

 

Non-cash adjustments

46,207

 

31,833

 

22,614

 

16,033

 

Tax paid

(3,786

)

(4,814

)

(2,466

)

(2,466

)

Net changes in working capital

(12,716

)

(3,314

)

9,396

 

10,864

 

Net cash from operating activities

36,422

 

51,623

 

32,048

 

35,036

 

 

 

 

 

 

INVESTING ACTIVITIES

 

 

 

 

Purchase of non-current assets (tangibles and intangibles)

(1,571

)

(2,200

)

(436

)

(1,393

)

Proceeds/(Loss) from disposal of non-current assets

36

 

(27

)

 

(30

)

Payment for acquisition of subsidiary, net of cash acquired

(5,900

)

(6,710

)

(5,832

)

(2,528

)

Other acquisition-related settlements

 

(6,680

)

 

 

Interest received

720

 

3,522

 

353

 

1,957

 

Net cash used in investing activities

(6,715

)

(12,095

)

(5,915

)

(1,994

)

 

 

 

 

 

FINANCING ACTIVITIES

 

 

 

 

Proceeds from sublease

64

 

87

 

34

 

31

 

Proceeds from bank loans

10,000

 

 

10,000

 

 

Repayment of borrowings

(30,842

)

 

(23,842

)

 

Repayment of lease liabilities

(6,159

)

(6,295

)

(3,066

)

(2,947

)

Repayment of lease interest

(989

)

(1,125

)

(482

)

(553

)

Interest and debt financing costs paid

(4,282

)

(583

)

(2,030

)

(296

)

Grant received

274

 

230

 

 

23

 

Proceeds from exercise of options

 

3,129

 

 

3,118

 

Net cash used in financing activities

(31,934

)

(4,557

)

(19,386

)

(624

)

Net change in cash and cash equivalents

(2,227

)

34,971

 

6,747

 

32,418

 

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

62,358

 

164,703

 

52,811

 

168,191

 

Exchange differences on cash and cash equivalents

(66

)

(1,072

)

507

 

(2,007

)

Cash and cash equivalents at the end of the period

60,065

 

198,602

 

60,065

 

198,602

 

 

RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS FINANCIAL MEASURES

RECONCILIATION OF REVENUE GROWTH/(DECLINE) RATE AS REPORTED UNDER IFRS TO REVENUE GROWTH/(DECLINE) RATE AT CONSTANT CURRENCY:

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

REVENUE GROWTH/(DECLINE) RATE AS REPORTED UNDER IFRS

5.0

%

(7.3

%)

6.6

%

(10.6

%)

Impact of Foreign exchange rate fluctuations

2.0

%

2.8

%

2.5

%

2.5

%

REVENUE GROWTH/(DECLINE) RATE AT CONSTANT CURRENCY

7.0

%

(4.5

%)

9.1

%

(8.1

%)

 

RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED PROFIT FOR THE PERIOD:

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

 

 

 

 

 

PROFIT BEFORE TAX

6,717

 

27,918

 

2,504

 

10,605

 

Adjustments:

 

 

 

 

Share-based compensation expense

21,965

 

23,556

 

10,944

 

13,617

 

Amortisation of acquired intangible assets

12,182

 

7,085

 

6,036

 

3,684

 

Foreign currency exchange (gains)/losses, net

(3,420

)

2,685

 

(2,574

)

4,764

 

Restructuring costs

5,494

 

 

5,494

 

 

Fair value movement of contingent consideration

(1,871

)

(8,706

)

(569

)

(9,942

)

Total adjustments

34,350

 

24,620

 

19,331

 

12,123

 

ADJUSTED PROFIT BEFORE TAX

41,067

 

52,538

 

21,835

 

22,728

 

 

 

 

 

 

PROFIT FOR THE PERIOD

9,098

 

20,713

 

6,851

 

8,347

 

Adjustments:

 

 

 

 

Adjustments to profit before tax

34,350

 

24,620

 

19,331

 

12,123

 

Release of Romanian withholding tax

(3,800

)

 

(3,800

)

 

Tax impact of adjustments

(6,682

)

(4,916

)

(4,511

)

(2,977

)

ADJUSTED PROFIT FOR THE PERIOD

32,966

 

40,417

 

17,871

 

17,493

 

 

 

 

 

 

RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER SHARE:

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

 

 

 

 

 

DILUTED EARNINGS PER SHARE (£)

0.15

 

0.35

 

0.11

 

0.14

 

Adjustments:

 

 

 

 

Share-based compensation expense

0.37

 

0.40

 

0.18

 

0.23

 

Amortisation of acquired intangible assets

0.20

 

0.12

 

0.10

 

0.06

 

Foreign currency exchange (gains)/losses, net

(0.06

)

0.05

 

(0.04

)

0.08

 

Restructuring costs

0.09

 

 

0.09

 

 

Fair value movement of contingent consideration

(0.02

)

(0.15

)

 

(0.16

)

Release of Romanian withholding tax

(0.06

)

 

(0.06

)

 

Tax impact of adjustments

(0.12

)

(0.08

)

(0.08

)

(0.05

)

Total adjustments

0.40

 

0.34

 

0.19

 

0.16

 

ADJUSTED DILUTED EARNINGS PER SHARE (£)

0.55

 

0.69

 

0.30

 

0.30

 

 

RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

 

 

 

 

 

NET CASH FROM OPERATING ACTIVITIES

36,422

 

51,623

 

32,048

 

35,036

 

Adjustments:

 

 

 

 

Grant received

274

 

230

 

 

23

 

Net purchase of non-current assets (tangibles and intangibles)

(1,535

)

(2,227

)

(436

)

(1,423

)

ADJUSTED FREE CASH FLOW

35,161

 

49,626

 

31,612

 

33,636

 

 

SUPPLEMENTARY INFORMATION
SHARE-BASED COMPENSATION EXPENSE

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Direct cost of sales

15,048

16,318

7,254

9,516

Selling, general and administrative expenses

6,917

7,238

3,690

4,101

Total

21,965

23,556

10,944

13,617

DEPRECIATION AND AMORTISATION

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

£’000

£’000

£’000

£’000

 

 

 

 

 

Direct cost of sales

10,413

10,049

5,233

4,853

Selling, general and administrative expenses

13,720

8,712

6,823

4,489

Total

24,133

18,761

12,056

9,342

EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT

 

Six Months Ended
December 31

Three Months Ended
December 31

 

2024

2023

2024

2023

 

 

 

 

 

Closing number of total employees (including directors)

11,668

 

11,539

 

11,668

 

11,539

 

Average operational employees

10,541

 

10,606

 

10,456

 

10,461

 

 

 

 

 

 

Top 10 customers %

34

%

34

%

36

%

34

%

Number of clients with > £1m of revenue

(rolling 12 months)

141

 

150

 

141

 

150

 

 

 

 

 

 

Geographic split of revenue %

 

 

 

 

North America

39

%

31

%

39

%

31

%

Europe

24

%

25

%

24

%

26

%

UK

32

%

35

%

32

%

34

%

Rest of World (RoW)

5

%

9

%

5

%

9

%

 

 

 

 

 

Industry vertical split of revenue %

 

 

 

 

Payments

19

%

27

%

19

%

26

%

Banking and Capital Markets

18

%

14

%

19

%

14

%

Insurance

9

%

8

%

9

%

8

%

TMT

20

%

23

%

19

%

23

%

Mobility

9

%

11

%

9

%

11

%

Healthcare

12

%

4

%

12

%

4

%

Other

13

%

13

%

13

%

14

%

 

FOOTNOTES

(1) Restated to include the effect of revisions arising from provisional to final acquisition accounting for DEK and Mudbath.

(2) The presentation of the Consolidated Statement of Cash Flows has been changed to separately present the repayment of lease interest from the total repayments of lease liabilities.

INVESTOR CONTACT:

Endava plc

Laurence Madsen, Head of Investor Relations

Investors@endava.com

Source: Endava plc

FAQ

What is the size of Endava's share repurchase program announced in Q2 FY2025?

Endava announced a $100 million share repurchase program, subject to shareholder approval at a general meeting planned for March 14, 2025.

How much did Endava's revenue grow in Q2 FY2025?

Endava's revenue grew 6.6% year-over-year to £195.6 million, or 9.1% at constant currency.

What is Endava's revenue guidance for Q3 FY2025?

Endava expects Q3 FY2025 revenue to be between £198.0-£200.0 million, representing constant currency growth of 13-14% year-over-year.

How many clients did Endava have with over £1 million in revenue as of December 2024?

As of December 31, 2024, Endava had 141 clients generating over £1 million in revenue on a rolling twelve-month basis.

What was DAVA's geographical revenue distribution in Q2 FY2025?

In Q2 FY2025, Endava generated 39% of revenue from North America, 24% from Europe, 32% from the United Kingdom, and 5% from the rest of the world.

Endava Plc

NYSE:DAVA

DAVA Rankings

DAVA Latest News

DAVA Stock Data

1.68B
59.20M
0.57%
81.09%
1.91%
Software - Infrastructure
Technology
Link
United Kingdom
London